OTC · Drug Manufacturers - Specialty & Generic

Juva Life Inc. (JUVAF) Stock

$0.00 OTC: JUVAF Healthcare

Juva Life Inc. is engaged in the cannabis industry, overseeing the acquisition, ownership, and management of businesses within both the medical and adult-use sectors.

Valuation

MetricValue
Price$0.00
Market Cap$1641
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.06
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-100.00%
ROA-50.00%
ROCE-46.03%
Gross Margin-133.33%
Operating Margin-133.33%
Net Margin-166.67%
Debt/Equity0.80
Current Ratio1.00

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$1.0M$4.0M$6.0M
Operating Profit$-1.0M$-7.0M$-10.0M$-10.0M$-8.0M
Net Profit$-3.0M$-9.0M$-16.0M$-11.0M$-10.0M
EPS$-0.04$-0.07$-0.13$-0.07$-0.06
Op Margin——-1063.9%-261.0%-140.9%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$3.0M$7.0M$16.0M$21.0M$20.0M
Total Liabilities$2.0M$7.0M$9.0M$6.0M$11.0M
Cash$2.0M$1.0M$2.0M$3.0M$1.0M
Borrowings$0$3.0M$2.0M$4.0M$8.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-1.0M$-3.0M$-6.0M$-9.0M$-7.0M
Investing Cash Flow$-1.0M$-4.0M$-17.0M$-3.0M$-10.0M
Financing Cash Flow$4.0M$3.0M$2.0M$0$0
Net Cash Flow$2.0M$-1.0M$1.0M$1.0M$-1.0M
Free Cash Flow$-2.0M$-5.0M$-15.0M$-11.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.08
FCF Yield-741040.95%
Quick Ratio0.98
Interest Coverage-4.46
Return 1Y0.00%
Return 3Y-99.97%
Return 5Y—

Ownership

Insiders Held30.83%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Vermillion Wealth Management, Inc. 2,5002026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AOXGAoxing Pharmaceutical Company, Inc. $0.00 — -86.98 $266756 0.00%
AQSZFAequus Pharmaceuticals Inc. $0.00 — -1.52 $159161 0.00%
CBDLCBD Life Sciences Inc. $0.00 — -29.85 $375394 0.00%
DVLPGolden Developing Solutions, Inc. $0.00 — 0.00 $1413 0.00%
GPFTGrapefruit USA, Inc. $0.00 — 0.17 $71740 0.00%

About Juva Life Inc.

Juva Life Inc. is engaged in the cannabis industry, overseeing the acquisition, ownership, and management of businesses within both the medical and adult-use sectors. The company was founded in 2018 and has its principal offices located in Vancouver, Canada.

Juva Life Inc. (JUVAF) stock trades at $0.00 with a market capitalization of $1641. The stock is valued at price-to-book of 0.00, price-to-sales of 0.00.

On profitability, Juva Life Inc. generates a return on equity (ROE) of -100.00% (negative, reflecting a net loss), return on capital employed of -46.03%, an operating margin of -133.33%, a net profit margin of -166.67%.

Official website: www.juvalife.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.